Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4+ T cells through regulating type 2 conventional dendritic cells.
Theranostics
; 13(14): 4836-4857, 2023.
Article
in En
| MEDLINE
| ID: mdl-37771774
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
T-Lymphocytes
/
Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Theranostics
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Australia